Gene editing in translational research
DNA read and write technologies have accelerated biotechnology at an unprecedented pace. This enhanced capacity to engineer living beings has accelerated not only scientific research, but also the translation into novel therapies. New approved medicinal products include the correction of the disease...
Main Author: | Marc Güell |
---|---|
Format: | Article |
Language: | Catalan |
Published: |
Universidad de Barcelona
2019-11-01
|
Series: | Revista de Bioética y Derecho |
Subjects: | |
Online Access: | http://revistes.ub.edu/index.php/RBD/article/view/28570 |
Similar Items
-
The Dubious Benefits of Germline Editing
by: Jennifer Gumer
Published: (2018-09-01) -
Gene Editing Regulation and Innovation Economics
by: Agustina I. Whelan, et al.
Published: (2020-04-01) -
CRISPR-Cas9 Germline Editing: Full Steam Ahead to Revolutionary Profit or Revolutionary Public Medicine?
by: Yuka Sai
Published: (2018-11-01) -
Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli
by: Francesca Zerbini, et al.
Published: (2017-04-01) -
CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues
by: Roberto Piergentili, et al.
Published: (2021-04-01)